These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23509241)

  • 1. Susceptibility of Streptococcus pyogenes to trimethoprim-sulfamethoxazole.
    Gelfand MS; Cleveland KO; Ketterer DC
    J Clin Microbiol; 2013 Apr; 51(4):1350. PubMed ID: 23509241
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to "Susceptibility of Streptococcus pyogenes to trimethoprim-sulfamethoxazole".
    Bowen AC; Tong SY; Carapetis JR
    J Clin Microbiol; 2013 Apr; 51(4):1351. PubMed ID: 23509242
    [No Abstract]   [Full Text] [Related]  

  • 3. Is Streptococcus pyogenes resistant or susceptible to trimethoprim-sulfamethoxazole?
    Bowen AC; Lilliebridge RA; Tong SY; Baird RW; Ward P; McDonald MI; Currie BJ; Carapetis JR
    J Clin Microbiol; 2012 Dec; 50(12):4067-72. PubMed ID: 23052313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Susceptibility of Streptococcus pyogenes isolated from invasive infections to trimethoprim-sulfamethoxazole].
    Vigliarolo L; Gazzeli L; Bonofiglio L; Mollerach M; Lopardo H
    Medicina (B Aires); 2018; 78(5):311-314. PubMed ID: 30285923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial Susceptibility of Invasive Streptococcus pyogenes Isolates in Germany during 2003-2013.
    Imöhl M; van der Linden M
    PLoS One; 2015; 10(9):e0137313. PubMed ID: 26340445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antistreptococcal activity of AR-709 compared to that of other agents.
    Smith K; Ednie LM; Appelbaum PC; Hawser S; Lociuro S
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2279-82. PubMed ID: 18362189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerococcus urinae and trimethoprim-sulfamethoxazole.
    Humphries RM; Lee C; Hindler JA
    J Clin Microbiol; 2011 Nov; 49(11):3934-5. PubMed ID: 21918023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Veterinary-Specific Interpretive Criteria for Susceptibility Testing of Streptococcus equi Subspecies with Trimethoprim-Sulfamethoxazole and Trimethoprim-Sulfadiazine.
    Sadaka C; Kanellos T; Guardabassi L; Boucher J; Watts JL
    J Clin Microbiol; 2017 Jan; 55(1):326-330. PubMed ID: 27847375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro synergism between rokitamycin and co-trimoxazole against Streptococcus pyogenes, Streptococcus pneumoniae and staphylococci.
    Roveta S; Marchese A; Debbia EA; Bandettini R
    Int J Antimicrob Agents; 2008 Feb; 31(2):185-7. PubMed ID: 18082375
    [No Abstract]   [Full Text] [Related]  

  • 10. Exogenous thymidine and reversal of the inhibitory effect of sulfamethoxazole-trimethoprim on streptococci.
    Coll PF; Ausina VR; Vernis JV; Mirelis BO; Prats GP
    Eur J Clin Microbiol; 1984 Oct; 3(5):424-6. PubMed ID: 6238821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of trimethoprim-sulfamethoxazole susceptibility testing methods for fastidious Haemophilus spp.
    Sierra Y; Tubau F; González-Díaz A; Carrera-Salinas A; Moleres J; Bajanca-Lavado P; Garmendia J; Domínguez MÁ; Ardanuy C; Martí S
    Clin Microbiol Infect; 2020 Jul; 26(7):944.e1-944.e7. PubMed ID: 31811916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of diaminopyrimidines and sulfonamides in Barbour-Stoenner-Kelly medium for isolation of Borrelia burgdorferi.
    Reisinger EC; Wendelin I; Gasser R
    Eur J Clin Microbiol Infect Dis; 1995 Aug; 14(8):732-3. PubMed ID: 8566001
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of dio-bacit, bacitracin-trimethoprim/ sulphamethoxazole and latex agglutination in the diagnosis of Group A beta-hemolytic streptococci.
    Altindis M; Aktepe OC; Kocagoz T
    Yonsei Med J; 2004 Feb; 45(1):56-60. PubMed ID: 15004869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of minimal amounts of thymidine on activity of trimethoprim-sulfamethoxazole against Staphylococcus epidermidis.
    Jones C; Stevens DL; Ojo O
    Antimicrob Agents Chemother; 1987 Feb; 31(2):144-7. PubMed ID: 3494425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to trimethoprim-sulfamethoxazole and modifications in genes coding for dihydrofolate reductase and dihydropteroate synthase in European Streptococcus pneumoniae isolates.
    Schmitz FJ; Perdikouli M; Beeck A; Verhoef J; Fluit AC;
    J Antimicrob Chemother; 2001 Dec; 48(6):935-6. PubMed ID: 11733486
    [No Abstract]   [Full Text] [Related]  

  • 16. Spurious sulfamethoxazole-trimethoprim resistance of Salmonella typhi.
    Escamilla J; Kilpatrick ME; Ugarte HF
    J Clin Microbiol; 1986 Jan; 23(1):205-6. PubMed ID: 3486190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of recently isolated pathogenic bacteria to trimethoprim and sulfamethoxazole separately and combined.
    Bach MC; Finland M; Gold O; Wilcox C
    J Infect Dis; 1973 Nov; 128():Suppl:508-33 p. PubMed ID: 4148416
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of three reference methods for testing susceptibility of staphylococci to trimethoprim-sulfamethoxazole.
    Griffith R; Creely D; Revell P; Dunne WM; Shortridge D
    J Clin Microbiol; 2009 Nov; 47(11):3726-8. PubMed ID: 19741069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpretive criteria and quality control parameters for testing of susceptibilities of Haemophilus influenzae and Streptococcus pneumoniae to trimethoprim and trimethoprim-sulfamethoxazole. The Antimicrobial Susceptibility Testing OC Group.
    Fuchs PC; Barry AL; Brown SD
    J Clin Microbiol; 1997 Jan; 35(1):125-31. PubMed ID: 8968893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro comparative study of Lidaprim and co-trimoxazole.
    Abdel-Messih EF; Suleiman MN; Baron JM
    J Int Med Res; 1984; 12(3):219-20. PubMed ID: 6376211
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.